 Bone marrow transplantation myelodysplasia secondary acute nonlymphoblastic leukemia Twenty-three patients primary myelodysplasia MDS secondary myelodysplasia/acute nonlymphocytic leukemia MDS/ANLL allogeneic bone marrow transplantation BMT patient chemotherapy-induced hematologic remission Graft-versus-host disease prophylaxis methotrexate methotrexate cyclosporine cyclosporine T-cell depletion monoclonal antibodies patients primary MDS median age years range years actuarial disease-free survival median follow-up years range years graft failures autologous recovery early deaths Outcome French-American-British FAB classification patients secondary MDS/ANLL median age years range years actuarial disease-free survival median follow-up years range years graft failures relapses early deaths presence marrow fibrosis se graft failure use T-cell marrow patients marrow fibrosis graft failure individuals results patients primary MDS secondary MDS/ANLL BMT course disease attempts remission BMT unnecessary MDS patients marrow fibrosis T-cell depletion